Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2

Structural Analysis of Chemokine Receptor–Ligand Interactions

Targeting lung inflammation: novel therapies for the treatment of COPD. - Abstract - Europe PMC

CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV. - Abstract - Europe PMC

KR100837019B1 - 3-4-heteroarylcyclohexylaminocyclopentanecarboxamides as modulators of chemokine receptors - Google Patents

Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2 (CCR2) Antagonists

MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY, CRYSTALLINE FORMS AND PROCESS - Patent 2046779

Selective and Dual Targeting of CCR2 and CCR5 Receptors: A Current Overview

Urotensin II Receptor Modulation with 1,3,4-Benzotriazepin-2-one Tetrapeptide Mimics

Pharmaceuticals, Free Full-Text